Mitchell Cairo
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion (NCT04099966) | Mitchell Cairo | 2021-04-01 |
Track Mitchell Cairo automatically
Every clearance here is in the API, with alerts when new ones post.